Strategic Financial Concepts LLC Takes Position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Strategic Financial Concepts LLC purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the fourth quarter, Holdings Channel reports. The institutional investor purchased 19,968 shares of the company’s stock, valued at approximately $1,312,000.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Wealth Enhancement Advisory Services LLC boosted its stake in shares of iShares U.S. Pharmaceuticals ETF by 11.0% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 3,589 shares of the company’s stock valued at $253,000 after buying an additional 356 shares during the period. FMR LLC boosted its position in iShares U.S. Pharmaceuticals ETF by 10.9% during the third quarter. FMR LLC now owns 13,581 shares of the company’s stock valued at $959,000 after purchasing an additional 1,338 shares during the last quarter. Jane Street Group LLC grew its stake in iShares U.S. Pharmaceuticals ETF by 5.5% in the third quarter. Jane Street Group LLC now owns 11,846 shares of the company’s stock valued at $836,000 after purchasing an additional 616 shares in the last quarter. Thrivent Financial for Lutherans increased its position in iShares U.S. Pharmaceuticals ETF by 23.6% in the 3rd quarter. Thrivent Financial for Lutherans now owns 32,509 shares of the company’s stock worth $2,295,000 after purchasing an additional 6,214 shares during the last quarter. Finally, Patten & Patten Inc. TN raised its stake in shares of iShares U.S. Pharmaceuticals ETF by 9.5% during the 3rd quarter. Patten & Patten Inc. TN now owns 25,813 shares of the company’s stock worth $1,823,000 after purchasing an additional 2,245 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Price Performance

Shares of iShares U.S. Pharmaceuticals ETF stock opened at $70.09 on Wednesday. The stock has a 50-day simple moving average of $67.52 and a 200-day simple moving average of $69.18. iShares U.S. Pharmaceuticals ETF has a 52-week low of $62.67 and a 52-week high of $72.94. The firm has a market cap of $707.91 million, a price-to-earnings ratio of 6.49 and a beta of 0.58.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.